Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Charles River Laboratories International Inc's Business Segments
Charles River Laboratories International Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
3
Largest Segment
Discovery and Safety Assessment
Total Revenue
$ 996
Regions Reported
2
Revenue Share by Reportable Segment - Q1 FY2026
- Discovery and Safety Assessment59.9%
- Research Models and Services20.9%
- Manufacturing Support19.1%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Discovery and Safety Assessment | $ 597 | 59.9% |
| Research Models and Services | $ 208 | 20.9% |
| Manufacturing Support | $ 191 | 19.1% |
Revenue Share by Region - Q1 FY2026
- Europe27.9%
- Asia Pacific5.6%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 278 | 27.9% |
| Asia Pacific | $ 55 | 5.6% |
Revenue by Product & Service Category - Q1 FY2026
- Service80.1%
- Product19.9%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Service | $ 798 | 80.1% |
| Product | $ 198 | 19.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Charles River Laboratories International Inc
Charles River Laboratories International, Inc. is a leading provider of research and preclinical services to help biotechnology, pharmaceutical, and other life sciences companies bring their products to market. The company is headquartered in Wilmington, Massachusetts and has more than 100 facilities around the world. Charles River Laboratories operates in three main business segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support.
The Research Models and Services segment provides laboratory animal models and associated services to help researchers understand disease and test new drugs. The company offers a range of products including mice, rats, guinea pigs, hamsters, and nonhuman primates. Additionally, Charles River Laboratories provides model creation and breeding, barrier and containment facilities, and research support services.
The Discovery and Safety Assessment segment offers preclinical research and safety assessment services to pharmaceutical and biotechnology companies. The company conducts studies to evaluate the safety and efficacy of potential new drugs, including toxicology studies and safety pharmacology studies. Charles River Laboratories also provides high-throughput screening services, in vitro ADME/DMPK services, and in vivo pharmacology and efficacy services.
The Manufacturing Support segment provides biologics testing services and support through end-to-end solutions to help customers get their products to market quickly and efficiently. The company offers a wide range of services including cGMP manufacturing support, viral clearance studies, and regulatory support services.
Through a combination of its diverse service offerings and global presence, Charles River Laboratories has become a trusted partner for many large and small biotechnology and pharmaceutical companies. The company is committed to making significant contributions to the development of new drugs and therapies that will help save and improve lives.
The Research Models and Services segment provides laboratory animal models and associated services to help researchers understand disease and test new drugs. The company offers a range of products including mice, rats, guinea pigs, hamsters, and nonhuman primates. Additionally, Charles River Laboratories provides model creation and breeding, barrier and containment facilities, and research support services.
The Discovery and Safety Assessment segment offers preclinical research and safety assessment services to pharmaceutical and biotechnology companies. The company conducts studies to evaluate the safety and efficacy of potential new drugs, including toxicology studies and safety pharmacology studies. Charles River Laboratories also provides high-throughput screening services, in vitro ADME/DMPK services, and in vivo pharmacology and efficacy services.
The Manufacturing Support segment provides biologics testing services and support through end-to-end solutions to help customers get their products to market quickly and efficiently. The company offers a wide range of services including cGMP manufacturing support, viral clearance studies, and regulatory support services.
Through a combination of its diverse service offerings and global presence, Charles River Laboratories has become a trusted partner for many large and small biotechnology and pharmaceutical companies. The company is committed to making significant contributions to the development of new drugs and therapies that will help save and improve lives.
Charles River Laboratories International Inc. is a leading global player in the life sciences sector, specializing in providing comprehensive early-stage drug discovery and development services. The company serves biopharmaceutical and biomedical industries through a diverse array of segments, products, and services.
Segments, Products and Services:
1. Research Models and Services Segment:
- Animal Models: Charles River Laboratories offers an extensive portfolio of animal models that includes rodents (such as rats and mice), dogs, cats, rabbits, and non-human primates. These models are critical for researchers, allowing for the evaluation of disease mechanisms and therapeutic interventions.
- Custom Model Generation Services: To meet the specific needs of their clients, Charles River offers tailored breeding and custom model generation services. This allows researchers to develop specific genetic or phenotypic characteristics in animal models that closely mimic human diseases.
- Scientific and Regulatory Support: The company provides substantial scientific expertise and regulatory guidance to support clients through the myriad of challenges associated with drug development. This includes assistance with study design, regulatory submissions, data interpretation, and compliance with industry standards.
- Research Services: Charles River also offers a range of research services that encompass drug discovery, efficacy testing, and targeted validation. The services include:
- In Vitro Discovery: Utilizing cell-based assays and biochemical tests to identify potential drug candidates.
- In Vivo Pharmacology: Conducting studies in animal models to evaluate the pharmacological effects of drug candidates.
- Virology: Providing specialized services to support the development of antiviral therapies.
Safety Assessment Segment:
- Toxicology Services: Charles River provides a broad spectrum of toxicology services, critical for assessing the safety of new compounds. The offerings include:
- Acute Toxicity Studies: Evaluating the effects of a single exposure to a test compound.
- Subacute and Chronic Toxicity Studies: Assessing the effects of repeated exposure over time to understand long-term safety.
- Carcinogenicity Studies: Systematic studies designed to evaluate whether a compound has the potential to cause cancer.
- Pathology Services: The company offers advanced pathology capabilities, which include:
- Histology: The study of the microscopic structure of tissues.
- Histopathology: Diagnosing diseases through the examination of tissue samples.
- Clinical Pathology: Laboratory analyses of blood, urine, and other bodily fluids to assess the health status of test subjects.
- Regulatory Support: Charles Rivers regulatory support services ensure compliance with industry standards such as Good Laboratory Practice (GLP), facilitating the approval processes necessary for new therapies.
Manufacturing Support Segment:
- Quality Control and Testing: This segment is vital for ensuring the safety and efficacy of drug products. Charles River offers:
- Analytical Testing: Comprehensive testing services to characterize compounds.
- Batch Release Testing: Quality assurance testing to confirm that each batch of product meets pre-established standards before being released to the market.
- Stability Testing: Monitoring the physical, chemical, and microbiological properties of drug products over time to confirm that they remain within acceptable limits.
- Contract Manufacturing Services: Charles River provides a suite of contract manufacturing options, including:
- Aseptic Fill and Finish Services: Ensuring that therapeutic biologics are filled and packaged under sterile conditions to maintain their integrity.
- Scale-up Support and Technology Transfer: Offering assistance to clients as they scale-up production processes from laboratory to full commercial scale. This includes transferring technology and ensuring that processes meet regulatory standards.
Conclusion:
Charles River Laboratories International Inc. stands out in the drug development landscape by providing a comprehensive suite of products and services that spans the entire drug discovery and development continuum. Through its specialized segments—Research Models and Services, Safety Assessment, and Manufacturing Support—the company equips biopharmaceutical and biomedical researchers with the tools, models, and support needed to advance innovative therapeutic solutions.
Segments, Products and Services:
1. Research Models and Services Segment:
- Animal Models: Charles River Laboratories offers an extensive portfolio of animal models that includes rodents (such as rats and mice), dogs, cats, rabbits, and non-human primates. These models are critical for researchers, allowing for the evaluation of disease mechanisms and therapeutic interventions.
- Custom Model Generation Services: To meet the specific needs of their clients, Charles River offers tailored breeding and custom model generation services. This allows researchers to develop specific genetic or phenotypic characteristics in animal models that closely mimic human diseases.
- Scientific and Regulatory Support: The company provides substantial scientific expertise and regulatory guidance to support clients through the myriad of challenges associated with drug development. This includes assistance with study design, regulatory submissions, data interpretation, and compliance with industry standards.
- Research Services: Charles River also offers a range of research services that encompass drug discovery, efficacy testing, and targeted validation. The services include:
- In Vitro Discovery: Utilizing cell-based assays and biochemical tests to identify potential drug candidates.
- In Vivo Pharmacology: Conducting studies in animal models to evaluate the pharmacological effects of drug candidates.
- Virology: Providing specialized services to support the development of antiviral therapies.
Safety Assessment Segment:
- Toxicology Services: Charles River provides a broad spectrum of toxicology services, critical for assessing the safety of new compounds. The offerings include:
- Acute Toxicity Studies: Evaluating the effects of a single exposure to a test compound.
- Subacute and Chronic Toxicity Studies: Assessing the effects of repeated exposure over time to understand long-term safety.
- Carcinogenicity Studies: Systematic studies designed to evaluate whether a compound has the potential to cause cancer.
- Pathology Services: The company offers advanced pathology capabilities, which include:
- Histology: The study of the microscopic structure of tissues.
- Histopathology: Diagnosing diseases through the examination of tissue samples.
- Clinical Pathology: Laboratory analyses of blood, urine, and other bodily fluids to assess the health status of test subjects.
- Regulatory Support: Charles Rivers regulatory support services ensure compliance with industry standards such as Good Laboratory Practice (GLP), facilitating the approval processes necessary for new therapies.
Manufacturing Support Segment:
- Quality Control and Testing: This segment is vital for ensuring the safety and efficacy of drug products. Charles River offers:
- Analytical Testing: Comprehensive testing services to characterize compounds.
- Batch Release Testing: Quality assurance testing to confirm that each batch of product meets pre-established standards before being released to the market.
- Stability Testing: Monitoring the physical, chemical, and microbiological properties of drug products over time to confirm that they remain within acceptable limits.
- Contract Manufacturing Services: Charles River provides a suite of contract manufacturing options, including:
- Aseptic Fill and Finish Services: Ensuring that therapeutic biologics are filled and packaged under sterile conditions to maintain their integrity.
- Scale-up Support and Technology Transfer: Offering assistance to clients as they scale-up production processes from laboratory to full commercial scale. This includes transferring technology and ensuring that processes meet regulatory standards.
Conclusion:
Charles River Laboratories International Inc. stands out in the drug development landscape by providing a comprehensive suite of products and services that spans the entire drug discovery and development continuum. Through its specialized segments—Research Models and Services, Safety Assessment, and Manufacturing Support—the company equips biopharmaceutical and biomedical researchers with the tools, models, and support needed to advance innovative therapeutic solutions.